Patents for C07K 19 - Hybrid peptides (29,428) |
---|
12/20/2006 | CN1880446A Antibody complexes |
12/20/2006 | CN1880336A Cancer-targeted super antigen fusion protein and its production method |
12/20/2006 | CN1879877A Tumour-specific animal proteins |
12/20/2006 | CN1290866C Anthrax toxin acceptor ATR-Fc fusion protein |
12/20/2006 | CN1290865C Transduction peptide-insecticidal crystal protein fused protein and its corresponding sequence and use |
12/20/2006 | CN1290864C Ant CD20 chimeric antibody |
12/20/2006 | CA2549086A1 Chimeric polypeptides and their therapeutic applications against a flaviviridae infection |
12/19/2006 | US7151168 Induction, controlling gene expression; genetic engineered plants |
12/19/2006 | US7150872 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
12/19/2006 | US7150869 Gene therapy; cytokine complex; anticancer agent |
12/19/2006 | CA2200423C Novel estrogen receptor |
12/14/2006 | WO2006133196A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
12/14/2006 | WO2006084179A3 Hiv tat-cd4 hybried molecules and methods of use thereof |
12/14/2006 | US20060281181 Adaptor-directed helper systems |
12/14/2006 | US20060281149 Transforming growth factor-beta-related molecules and uses thereof |
12/14/2006 | US20060281146 Novel compositions and methods for the treatment of immune related diseases |
12/14/2006 | US20060281080 Novel lipases and uses thereof |
12/14/2006 | US20060280750 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity |
12/14/2006 | US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
12/14/2006 | CA2609865A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
12/13/2006 | EP1731531A2 Multiple cytokine-antibody complexes |
12/13/2006 | EP1731530A1 A kind of fusion protein, gene encoding it, expression method and use thereof |
12/13/2006 | EP1730536A2 Methods for detecting calcium ion influx |
12/13/2006 | EP1730198A2 Adzymes and uses thereof |
12/13/2006 | EP1354204B1 Hcv antigen/antibody combination assay |
12/13/2006 | EP1206554B1 Activatable recombinant neurotoxins |
12/13/2006 | EP1124961B1 Thrombopoietic compounds |
12/13/2006 | EP1117795B1 Tgf-beta superfamily mutant members, including morphogenic proteins |
12/13/2006 | EP0980429B1 Human toll-like receptor proteins, related reagents and methods |
12/13/2006 | CN1876684A A series of polypeptide capable of blocking IL-6 and its medicinal uses |
12/13/2006 | CN1289673C Anemone neurotoxin gene Sr6 and application thereof |
12/13/2006 | CN1289671C Antibody molecules having specificity for human tumor necrosis factory alpha, and use thereof |
12/13/2006 | CN1289525C T2R-novel family of taste receptors |
12/12/2006 | US7148338 Comprises nucleotide sequences coding oligopeptidase for use in screening compounds for treatment of cell proliferative and metabolic disorders; enzyme inhibitors |
12/12/2006 | US7148321 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype |
12/12/2006 | US7148058 Solid support for use in the detection of preferential protein complexes in sample |
12/12/2006 | US7148045 Complex multienzyme with loading domain linked to extension domains and adds a ketide for decarboxylation. |
12/12/2006 | US7148038 Immunotherapy; antiproliferative agent |
12/12/2006 | US7148030 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
12/12/2006 | US7148013 Complex of Hepatitis B virus polymerase with p11 and method for controlling movement of the complex in HepG2 cell |
12/07/2006 | WO2006129849A1 Anti-cd14 antibody-fused protein |
12/07/2006 | WO2006129828A2 Target substance capturing molecule |
12/07/2006 | WO2006109303A3 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
12/07/2006 | WO2006089141A3 Antibodies against cxcr4 and methods of use thereof |
12/07/2006 | WO2006066596A3 Hybrid enzymes consisting of an endo-amylase first amino acid sequence and a carbohydrate -binding module as second amino acid sequence |
12/07/2006 | US20060276633 Method for the mass production of immunoglobulin constant region |
12/07/2006 | US20060276396 Stimulating insulin synthesis and release, enhancing adipose, muscle or liver tissue sensitivity towards insulin uptake, stimulating glucose uptake, slowing digestive process, or blocking the secretion of glucagon; glucagon-like protein |
12/07/2006 | US20060275868 Fusion proteins comprising tumor necrosis factor receptor |
12/07/2006 | US20060275758 Use of pp2a phosphatase modulators in the treatment of mental disorders |
12/07/2006 | US20060275297 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal |
12/07/2006 | US20060275254 covalently linked to a drug that is a physiologically active polypeptide through a non-peptide linker; nonimmunogenic; extended serum half-life of a drug while maintaining the in vivo activity |
12/07/2006 | DE10161899B4 Fusionsproteine gegen die Hodgkin-Krankheit Fusion proteins for Hodgkin's disease |
12/07/2006 | DE10161738B4 Fusionsproteine gegen T-Zell-Tumore Fusion proteins against T-cell tumors |
12/07/2006 | CA2609262A1 Anti-cd14 antibody fusion protein |
12/06/2006 | EP1728864A1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
12/06/2006 | EP1728800A1 Papilloma virus-like particles, fusion proteins and process for producing the same |
12/06/2006 | EP1456222A4 Non-human primate fc receptors and methods of use |
12/06/2006 | EP1007686B1 Tuberculosis vaccine |
12/06/2006 | CN1873005A Conjugated protein Tau of microtubule of earthworm, its coding gene, and application |
12/06/2006 | CN1872881A Long effective amalgamation protein of erythropoietin of human, preparing and purifying methods |
12/06/2006 | CN1872880A Guidance quality peptide of nascent blood vessel of gastric cancer, and new type amalgamation protein of necrosin of human tumour |
12/06/2006 | CN1872877A Idiosyncratic antigen protein, and antigen peptide of liver cancer orchis pellet |
12/05/2006 | CA2246802C A human cytomegalovirus combined antigen and its use |
11/30/2006 | WO2006128196A2 Novel substrate for rpn 11 enzymatic activity |
11/30/2006 | WO2004047728A3 Compositions and methods for the treatment of immune related diseases |
11/30/2006 | US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis |
11/30/2006 | US20060269553 a protein conjugate comprising a physiologically active polypeptide, a non-peptide polymer and an immunoglobulin Fc fragment, with improved in vivo duration and stability; nonimmunogenic |
11/30/2006 | CA2609271A1 Novel substrate for rpn 11 enzymatic activity |
11/29/2006 | EP1353953B1 Mu-1, member of the cytokine receptor family |
11/29/2006 | EP1158993B1 Bacterial membrane fractions with adjuvant effect |
11/29/2006 | EP1092027B1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same |
11/29/2006 | CN1871258A Fusion polypeptides, and use thereof in antivascular tumor therapy |
11/29/2006 | CN1871255A Novel secretory protein and production process and use thereof |
11/29/2006 | CN1869214A Method for high efficiency expressing destination protein |
11/29/2006 | CN1869073A Antibody of EPSPS enzyme and its prepuration method and special antigen and application |
11/29/2006 | CN1869072A Nerve growth factor combined with collagen specificity and its coading gene and application |
11/29/2006 | CN1869071A Recombination immune therapeutic protein and its expression method and application |
11/29/2006 | CN1286976C Interferon-alpha/beta binding protein, its preparation and use |
11/28/2006 | US7141656 In situ screening, isolation of peptides; major histocompability complex |
11/28/2006 | US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders |
11/28/2006 | US7141651 Multiple cytokine protein complexes |
11/28/2006 | US7141547 Albumin fusion proteins comprising GLP-1 polypeptides |
11/28/2006 | US7141391 Monkey and canine melanin concentrating hormone receptors |
11/23/2006 | WO2006122787A1 Serum albumin binding proteins |
11/23/2006 | WO2006122512A1 Fusion proteins comprising protein transduction domain, auxiliary protein and bioactive protein, their production and uses |
11/23/2006 | WO2006090241A3 Method of creating or selecting recombinant genes |
11/23/2006 | WO2006047250A3 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
11/23/2006 | US20060265764 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same |
11/23/2006 | US20060264615 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12; site directed mutagenesis |
11/23/2006 | US20060264613 Soluble CTLA4 proteins produced by recombinant DNA methods; autoimmune diseases, transplant rejection; inhibits the co-stimulatory pathway in T cell activation |
11/23/2006 | US20060263856 Expression technology for proteins containing a hybrid isotype antibody moiety |
11/23/2006 | CA2853335A1 Hivcon: an hiv immunogen and uses thereof |
11/23/2006 | CA2607305A1 Anti-mesothelin antibodies useful for immunological assays |
11/23/2006 | CA2607291A1 Compositions and methods for modulating immune responses |
11/22/2006 | EP1724349A1 TIE Ligand Homologues |
11/22/2006 | EP1724284A2 GLP-1 fusion proteins |
11/22/2006 | EP1723173A1 Il-4/il-13 sepecific polypetides and therapeutic uses thereof |
11/22/2006 | EP1511770B1 Glycoprotein vi-fc fusion protein for the treatment of vascular diseases |
11/22/2006 | EP1071774B1 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof |
11/22/2006 | EP0939821B1 G-beta-gamma regulated phosphatidylinositol-3' kinase |